English
Back
Download
Log in to access Online Inquiry
Back to the Top
avatar
Jaguar8 commented on a stock · Oct 15, 2024 21:02

NEWS

Seelos Therapeutics Announces Notice of Delisting from Nasdaq and Transfer of Listing to Over-the-Counter Market
Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company, has received notice of delisting from Nasdaq due to non-compliance with the minimum stockholder's equity requirement. The company's common stock will be suspended from trading on Nasdaq effective October 16, 2024, and is expected to begin trading on the OTCQB on the same date.
The Nasdaq Hearings Panel had previously given Seelos until October 11, 2024, to regain compliance with the Equity Standard Rule. However, the company failed to meet this requirement. Seelos cautions that there is no assurance that a broker will continue to make a market in the company's common stock or that trading will continue on an over-the-counter market or elsewhere.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
3
Translate
Report
3624 Views
Comment
Sign in to post a comment
avatar
Jaguar8
Spread kindness and love. Life is short. Don’t let greed eat you.
6636
Followers
44
Following
71K
Visitors
Follow
Heat List
US
SymbolMini ChartLatest Price
NVDA
NVIDIA
-- 131.760
TSLA
Tesla
-- 396.360
RGTI
Rigetti Computing
-- 8.9500
AMD
Advanced Micro Devices
-- 116.090
PLTR
Palantir
-- 65.910
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
Trump 2.0 countdown: What's the next big opportunity in the markets?
🎙️️ Discussion: 1. Could Trump's cryptocurrency policies potentially benefit the crypto market? 2. Might his tariff policies have a positiv Show More
Trump 2.0 Opportunity Preview: Guess the market winner before the president takes office!